Italy · Medical devices startup
Italy · BetaGlue Therapeutics
BetaGlue Therapeutics is an Italian clinical-stage oncology company based in Milan.
Funding reportedLast round: Undisclosed round
Follow BetaGlue Therapeutics and see its new rounds in your feed.Start following
About BetaGlue Therapeutics
BetaGlue Therapeutics is an Italian clinical-stage oncology company based in Milan.
Founded in 2009, the company focuses on developing targeted nuclear therapies for unresectable solid tumors. Its lead product, YntraDose®, is designed for the localized treatment of pancreatic cancer, specifically unresectable locally advanced pancreatic cancer. YntraDose® utilizes a proprietary radiotherapy platform that delivers radiation directly into tumors using Yttrium-90 microspheres embedded in a biocompatible glue. This targeted delivery method minimizes off-target effects and enhances treatment efficacy. BetaGlue Therapeutics is committed to transforming nuclear science into effective cancer treatments, aiming to set a new standard of care in radiotherapy. The company is actively developing personalized radiotherapy solutions and has received regulatory approval for clinical trials in the UK.
What company datasets say BetaGlue Therapeutics raised
Funding, as reported
Founders and team
From BetaGlue Therapeutics's own website: 7 on the team.
- Salvatore CalabreseChief Financial Officer (CFO)
- Dr. Carol HegartyHead of Clinical Operations
- Dr. Pieter JanssenHead of Product Development
- Francesco BerriHead of M&A & Business Development at LIFTT
- Pietro Bubba BelloHead of Manufacturing & Operations
- Alexis PeyrolesChairman Inside Tx & OWL Life Sciences
- Mike CogswellChairman of DermaCure RT & EbaMed SA
The company, in detail
What they build
Known for
treatment efficacyhealth carebiocompatible bioglueorgan preservationinterventional radiologysingle session radiotherapyintratumoral injectiononcology innovationpancreasimaging guidancemedical equipment manufacturingcancer patient groupspersonalized cancer treatmentpercutaneous radiotherapyhospital & health caremedical
Built with from their website
Yoast SEOGoogle MapsContact Form 7WordPress.orgFont AwesomeCloudFlareViewport MetaVisual ComposerYoastElement UI
+8 more
Google Maps (Non Paid Users)WordpressMicrosoft Exchange OnlinejQuery MigrateRedux FrameworkcdnjsPriority HintsCAPTCHA
- Sector
- Medical devices
- Industry code
- NAICS 541714, 339112, SIC 8731
- Region
- Lombardy
- Full record
- Every detail in the company directory
Medical devices in Italy
Startups like it
Is this your company?
Add your raise, your deck and your story, and put BetaGlue Therapeutics in front of investors. Or tell us what we have wrong.